Arterial Capital Management is a private equity firm focused exclusively on the global life science sector. We specialise in providing equity funding to biotech, medtech and pharmaceutical companies.

1. capital management
PIONEERING LIFE SCIENCE INVESTMENT

2. capital management
Arterial Capital Management is a private equity firm focused exclusively
on the global life science sector. We specialise in providing equity
funding to biotech, medtech and pharmaceutical companies.
Our investment approach is to fund well-researched, innovative projects,
with proven management teams, recognised trial data, strong IP and a
demonstrable opportunity for significant commercial upside. We target
investee firms with an appetite for strong corporate governance, a desire
to build a scalable business and the potential to return 5-20 times the
gross investment within a three to six year timescale. Such opportunities
are uncommon, but do exist.

3. capital management
At Arterial, our approach enables us to select the best investment
opportunities available, attributable largely to the global reputation of our
team, and their proven track record across the life science sector.
In summary Arterial’s financial success is directly related to the financial
return of all parties. We typically invest personally into each project on
the same terms as other investors and we are motivated primarily by a
traditional 20% carried interest on the successful realisation of a holding;
thereby never losing sight of the fact that we all share a common goal –
the conversion of outstanding science into commercial reality.

4. capital management
e: info@artcapman.com
w: www.artcapman.com
Main Office
Suite 15, 1st Floor
Oliaji Trade Centre
Francis Rachel Street
Victoria
Mahe
Seychelles
PIONEERING LIFE SCIENCE INVESTMENT